Associated Papers
Strategies for identifying NUP98 rearrangements in adult myeloid neoplasms.
Yuen LD et al.
Haematologica, 2026
40820841 (PubMed )
Supplement: 2025_288080_YUEN_TABLES_SUPPL.xlsx › Suppl_table_2_all_mutations
A Comprehensive Guide to Achieving New York State Clinical Laboratory Evaluation Program Approval for Next-Generation Sequencing Assays.
Galbo PM et al.
The Journal of Molecular Diagnostics : Jmd, 2025
40158885 (PubMed )
Supplement: mmc9.xlsx › Sheet1
RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group.
Sendker S et al.
Leukemia, 2023
Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial.
Fenwarth L et al.
Haematologica, 2021
32554555 (PubMed )
Supplement: 2020_248872_FENWARTH_SUPPL.pdf
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
Becker H et al.
Annals of Hematology, 2020
32504186 (PubMed )
Supplement: 277_2020_4082_MOESM1_ESM.pdf
Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS.
Luo S et al.
Oncotargets and Therapy, 2020
Select a paper to view details